Key Points
- CEO Stephen Beard sold 3,545 Adtalem shares for approximately $462,055 under a pre-arranged Rule 10b5-1 trading plan, reducing his holdings by 0.85% to 415,197 shares.
- Adtalem reported quarterly EPS of $2.09, beating estimates of $1.90, on revenue of $501.38 million. The company issued fiscal 2027 EPS guidance of $8.90–$9.15.
- Institutional investors own 98.84% of the stock, while analysts maintain a “Moderate Buy” consensus with an average price target of $155, above the reported $132.20 opening price.
Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CEO Stephen Beard sold 3,545 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total transaction of $462,055.30. Following the sale, the chief executive officer owned 415,197 shares of the company's stock, valued at $54,116,776.98. This trade represents a 0.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Stock Up 3.1%
NYSE:CVSA opened at $132.20 on Friday. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 18.78, a PEG ratio of 0.95 and a beta of 0.62. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. The company has a 50-day moving average price of $125.16.
Adtalem Global Education (NYSE:CVSA - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.19. The company had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, research analysts expect that Adtalem Global Education Inc. will post 8.99 EPS for the current fiscal year.
Hedge Funds Weigh In On Adtalem Global Education
A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,622 shares of the company's stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on CVSA shares. Wall Street Zen raised Adtalem Global Education from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Truist Financial boosted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Weiss Ratings restated a "hold (c+)" rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Finally, Barrington Research restated an "outperform" rating and issued a $170.00 target price on shares of Adtalem Global Education in a research note on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $155.00.
Check Out Our Latest Stock Report on CVSA
About Adtalem Global Education
(
Get Free Report)
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
